EMA — authorised 9 December 2022
- Marketing authorisation holder: NOVARTIS EUROPHARM LIMITED
- Status: approved
🇪🇺 Pluvicto in European Union
EMA authorised Pluvicto on 9 December 2022
Marketing authorisation
Pluvicto in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Pluvicto approved in European Union?
Yes. EMA authorised it on 9 December 2022.
Who is the marketing authorisation holder for Pluvicto in European Union?
NOVARTIS EUROPHARM LIMITED holds the EU marketing authorisation.